Circulating soluble CD36 as a novel biomarker for progression and prognosis of HBV-related liver diseases

por Cai, Chunxian, Xiao, Anhua, Luo, Xiaoqing, Zheng, Enze, Li, Yiyu, Lei, Yu, Zhong, Shan, Chen, Yaxi, Yang, Ping, Tang, Zhurong, Zhou, Zhi
Publicado 2022

The fatty acid receptor CD36 promotes HCC progression through activating Src/PI3K/AKT axis-dependent aerobic glycolysis

por Luo, Xiaoqing, Zheng, Enze, Wei, Li, Zeng, Han, Qin, Hong, Zhang, Xiaoyu, Liao, Meng, Chen, Lin, Zhao, Lei, Ruan, Xiong Z., Yang, Ping, Chen, Yaxi
Publicado 2021

CD36 promotes de novo lipogenesis in hepatocytes through INSIG2-dependent SREBP1 processing

por Zeng, Han, Qin, Hong, Liao, Meng, Zheng, Enze, Luo, Xiaoqing, Xiao, Anhua, Li, Yiyu, Chen, Lin, Wei, Li, Zhao, Lei, Ruan, Xiong Z., Yang, Ping, Chen, Yaxi
Publicado 2021

CD36-mediated metabolic crosstalk between tumor cells and macrophages affects liver metastasis

por Yang, Ping, Qin, Hong, Li, Yiyu, Xiao, Anhua, Zheng, Enze, Zeng, Han, Su, Chunxiao, Luo, Xiaoqing, Lu, Qiannan, Liao, Meng, Zhao, Lei, Wei, Li, Varghese, Zac, Moorhead, John F., Chen, Yaxi, Ruan, Xiong Z.
Publicado 2022